Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
19
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Sirota Eric | Chief Operating Officer | 3 | $0 | $0 | 2013-10-24 |
| Schaum Meredith | Gen.Counsel and Chief Comp Off | 4 | $0 | $0 | 2013-10-24 |
| Webster Stephen W | Chief Financial Officer | 6 | $0 | $0 | 2013-10-24 |
| Newman Stephen L | Director | 3 | $0 | $0 | 2013-10-24 |
| Chang Michael N | Director | 32 | $0 | $0 | 2013-10-24 |
| Gorbach MD Sherwood | SVP, Chief Scientific Officer | 14 | $0 | $0 | 2013-10-24 |
| ZERBE ROBERT L MD | Director | 9 | $0 | $0 | 2013-10-24 |
| AMPER LINDA E | SVP, Human Resources | 4 | $0 | $0 | 2013-10-24 |
| ALTIG ANTHONY E | Director | 11 | $0 | $0 | 2013-10-24 |
| GREBOW PETER E | Director | 10 | $0 | $0 | 2013-10-24 |
| CHANG JOSEPH Y | Director | 17 | $0 | $53.0K | 2013-10-24 |
| MCKINNELL HENRY A | Director | 10 | $0 | $0 | 2013-10-24 |
| AUERBACH MARK | Director | 11 | $0 | $0 | 2013-10-24 |
| LICHTINGER PEDRO | Other | 9 | $99.9K | $2.17M | 2013-04-08 |
| Hartman Kurt M | General Counsel, SVP | 2 | $0 | $0 | 2012-08-11 |
| Papaz Gregory E. | SVP, Commercial Operations | 2 | $0 | $0 | 2012-05-15 |
| Shue Youe Kong | VP, Clinical Development | 1 | $0 | $0 | 2012-02-07 |
| Prunty John D | CFO and SVP, Finance | 1 | $0 | $0 | 2012-02-07 |
| Che Tessie M | COO and SVP | 1 | $0 | $0 | 2012-01-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| ALTIG ANTHONY E | Director | D To issuer deriv | 2013-10-24 | 2013-10-25 | 10,000 | $5.68 | $56.8K | 0 | SEC↗ |
| ALTIG ANTHONY E | Director | D To issuer deriv | 2013-10-24 | 2013-10-25 | 5,000 | $2.03 | $10.1K | 0 | SEC↗ |
| ALTIG ANTHONY E | Director | D To issuer deriv | 2013-10-24 | 2013-10-25 | 10,000 | $0.93 | $9.3K | 0 | SEC↗ |
| ALTIG ANTHONY E | Director | D To issuer deriv | 2013-10-24 | 2013-10-25 | 10,000 | $3.22 | $32.2K | 0 | SEC↗ |
| ALTIG ANTHONY E | Director | D To issuer deriv | 2013-10-24 | 2013-10-25 | 5,000 | $5.68 | $28.4K | 0 | SEC↗ |
| CHANG JOSEPH Y | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 3,461 | $10.61 | $36.7K | 0 | SEC↗ |
| CHANG JOSEPH Y | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 3,461 | $11.70 | $40.5K | 0 | SEC↗ |
| CHANG JOSEPH Y | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 3,461 | $11.70 | $40.5K | 0 | SEC↗ |
| CHANG JOSEPH Y | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 3,461 | $10.61 | $36.7K | 0 | SEC↗ |
| CHANG JOSEPH Y | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 5,000 | $5.68 | $28.4K | 0 | SEC↗ |
| CHANG JOSEPH Y | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 5,000 | $2.03 | $10.1K | 0 | SEC↗ |
| CHANG JOSEPH Y | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 10,000 | $0.93 | $9.3K | 0 | SEC↗ |
| CHANG JOSEPH Y | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 10,000 | $3.22 | $32.2K | 0 | SEC↗ |
| Chang Michael N | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 80,000 | $2.03 | $162.4K | 0 | SEC↗ |
| Chang Michael N | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 80,000 | $0.93 | $74.4K | 0 | SEC↗ |
| Chang Michael N | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 2,000 | $3.22 | $6.4K | 0 | SEC↗ |
| Chang Michael N | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 30,000 | $0.93 | $27.9K | 0 | SEC↗ |
| Chang Michael N | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 11,000 | $1.37 | $15.1K | 0 | SEC↗ |
| AUERBACH MARK | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 3,461 | $10.61 | $36.7K | 0 | SEC↗ |
| AUERBACH MARK | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 5,000 | $5.68 | $28.4K | 0 | SEC↗ |
| AUERBACH MARK | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 10,000 | $3.22 | $32.2K | 0 | SEC↗ |
| AUERBACH MARK | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 5,000 | $2.03 | $10.1K | 0 | SEC↗ |
| AUERBACH MARK | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 10,000 | $0.93 | $9.3K | 0 | SEC↗ |
| ZERBE ROBERT L MD | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 10,000 | $0.93 | $9.3K | 0 | SEC↗ |
| ZERBE ROBERT L MD | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 10,000 | $1.88 | $18.8K | 0 | SEC↗ |
| ZERBE ROBERT L MD | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 10,000 | $0.93 | $9.3K | 0 | SEC↗ |
| ZERBE ROBERT L MD | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 10,000 | $3.22 | $32.2K | 0 | SEC↗ |
| GREBOW PETER E | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 10,000 | $3.22 | $32.2K | 0 | SEC↗ |
| GREBOW PETER E | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 10,000 | $0.93 | $9.3K | 0 | SEC↗ |
| GREBOW PETER E | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 10,000 | $0.93 | $9.3K | 0 | SEC↗ |
| GREBOW PETER E | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 5,000 | $1.93 | $9.7K | 0 | SEC↗ |
| GREBOW PETER E | Director | D To issuer deriv | 2013-10-24 | 2013-10-28 | 10,000 | $1.93 | $19.3K | 0 | SEC↗ |
| MCKINNELL HENRY A | CEO and Chairman of the Boar | D To issuer deriv | 2013-10-24 | 2013-10-28 | 20,000 | $1.11 | $22.2K | 0 | SEC↗ |
| MCKINNELL HENRY A | CEO and Chairman of the Boar | D To issuer deriv | 2013-10-24 | 2013-10-28 | 10,000 | $1.11 | $11.1K | 0 | SEC↗ |
| MCKINNELL HENRY A | CEO and Chairman of the Boar | D To issuer deriv | 2013-10-24 | 2013-10-28 | 225,000 | $2.06 | $463.5K | 0 | SEC↗ |
| Gorbach MD Sherwood | SVP, Chief Scientific Office | D To issuer deriv | 2013-10-24 | 2013-10-28 | 100,000 | $6.19 | $619.0K | 0 | SEC↗ |
| Gorbach MD Sherwood | SVP, Chief Scientific Office | D To issuer deriv | 2013-10-24 | 2013-10-28 | 12,000 | $0.93 | $11.2K | 0 | SEC↗ |
| Gorbach MD Sherwood | SVP, Chief Scientific Office | D To issuer deriv | 2013-10-24 | 2013-10-28 | 20,000 | $3.75 | $75.0K | 0 | SEC↗ |
| Gorbach MD Sherwood | SVP, Chief Scientific Office | D To issuer deriv | 2013-10-24 | 2013-10-28 | 60,000 | $2.06 | $123.6K | 0 | SEC↗ |
| Gorbach MD Sherwood | SVP, Chief Scientific Office | D To issuer deriv | 2013-10-24 | 2013-10-28 | 1,298 | $11.70 | $15.2K | 0 | SEC↗ |
| Gorbach MD Sherwood | SVP, Chief Scientific Office | D To issuer deriv | 2013-10-24 | 2013-10-28 | 11,610 | $11.70 | $135.8K | 0 | SEC↗ |
| Gorbach MD Sherwood | SVP, Chief Scientific Office | D To issuer deriv | 2013-10-24 | 2013-10-28 | 7,500 | $5.88 | $44.1K | 0 | SEC↗ |
| Gorbach MD Sherwood | SVP, Chief Scientific Office | D To issuer deriv | 2013-10-24 | 2013-10-28 | 40,000 | $1.37 | $54.8K | 0 | SEC↗ |
| Webster Stephen W | Chief Financial Officer | D To issuer deriv | 2013-10-24 | 2013-10-28 | 60,000 | $2.06 | $123.6K | 0 | SEC↗ |
| AMPER LINDA E | SVP, Human Resources | D To issuer deriv | 2013-10-24 | 2013-10-28 | 30,000 | $2.06 | $61.8K | 0 | SEC↗ |
| AMPER LINDA E | SVP, Human Resources | D To issuer deriv | 2013-10-24 | 2013-10-28 | 100,000 | $1.37 | $137.0K | 0 | SEC↗ |
| Schaum Meredith | Gen Counsel and Chief Comp O | D To issuer deriv | 2013-10-24 | 2013-10-28 | 30,000 | $2.06 | $61.8K | 0 | SEC↗ |
| ALTIG ANTHONY E | Director | D To issuer | 2013-10-24 | 2013-10-25 | 7,500 | $10.75 | $80.6K | 0 | SEC↗ |
| ALTIG ANTHONY E | Director | D To issuer | 2013-10-24 | 2013-10-25 | 5,000 | $10.75 | $53.8K | 15,000 | SEC↗ |
| ALTIG ANTHONY E | Director | D To issuer | 2013-10-24 | 2013-10-25 | 7,500 | $10.75 | $80.6K | 7,500 | SEC↗ |
| CHANG JOSEPH Y | Director | D To issuer | 2013-10-24 | 2013-10-28 | 7,500 | $10.75 | $80.6K | 0 | SEC↗ |
| CHANG JOSEPH Y | Director | D To issuer | 2013-10-24 | 2013-10-28 | 46,154 | $10.75 | $496.2K | 0 | SEC↗ |
| CHANG JOSEPH Y | Director | D To issuer | 2013-10-24 | 2013-10-28 | 10,000 | $10.75 | $107.5K | 7,500 | SEC↗ |
| Chang Michael N | Director | D To issuer | 2013-10-24 | 2013-10-28 | 1,026,956 | $10.75 | $11.04M | 0 | SEC↗ |
| Chang Michael N | Director | D To issuer | 2013-10-24 | 2013-10-28 | 441,761 | $10.75 | $4.75M | 0 | SEC↗ |
| AUERBACH MARK | Director | D To issuer | 2013-10-24 | 2013-10-28 | 10,000 | $10.75 | $107.5K | 10,000 | SEC↗ |
| AUERBACH MARK | Director | D To issuer | 2013-10-24 | 2013-10-28 | 10,000 | $10.75 | $107.5K | 0 | SEC↗ |
| ZERBE ROBERT L MD | Director | D To issuer | 2013-10-24 | 2013-10-28 | 7,500 | $10.75 | $80.6K | 7,500 | SEC↗ |
| ZERBE ROBERT L MD | Director | D To issuer | 2013-10-24 | 2013-10-28 | 7,500 | $10.75 | $80.6K | 0 | SEC↗ |
| GREBOW PETER E | Director | D To issuer | 2013-10-24 | 2013-10-28 | 7,500 | $10.75 | $80.6K | 0 | SEC↗ |
| GREBOW PETER E | Director | D To issuer | 2013-10-24 | 2013-10-28 | 7,500 | $10.75 | $80.6K | 7,500 | SEC↗ |
| Newman Stephen L | Director | D To issuer | 2013-10-24 | 2013-10-28 | 7,500 | $10.75 | $80.6K | 0 | SEC↗ |
| MCKINNELL HENRY A | CEO and Chairman of the Boar | D To issuer | 2013-10-24 | 2013-10-28 | 10,000 | $10.75 | $107.5K | 25,000 | SEC↗ |
| MCKINNELL HENRY A | CEO and Chairman of the Boar | D To issuer | 2013-10-24 | 2013-10-28 | 10,000 | $10.75 | $107.5K | 0 | SEC↗ |
| MCKINNELL HENRY A | CEO and Chairman of the Boar | D To issuer | 2013-10-24 | 2013-10-28 | 15,000 | $10.75 | $161.3K | 10,000 | SEC↗ |
| Gorbach MD Sherwood | SVP, Chief Scientific Office | D To issuer | 2013-10-24 | 2013-10-28 | 2,333 | $10.75 | $25.1K | 0 | SEC↗ |
| Gorbach MD Sherwood | SVP, Chief Scientific Office | D To issuer | 2013-10-24 | 2013-10-28 | 39,886 | $10.75 | $428.8K | 2,333 | SEC↗ |
| Webster Stephen W | Chief Financial Officer | D To issuer | 2013-10-24 | 2013-10-28 | 16,666 | $10.75 | $179.2K | 0 | SEC↗ |
| Webster Stephen W | Chief Financial Officer | D To issuer | 2013-10-24 | 2013-10-28 | 8,334 | $10.75 | $89.6K | 16,666 | SEC↗ |
| Sirota Eric | Chief Operating Officer | D To issuer | 2013-10-24 | 2013-10-28 | 10,000 | $10.75 | $107.5K | 0 | SEC↗ |
| Sirota Eric | Chief Operating Officer | D To issuer | 2013-10-24 | 2013-10-28 | 2,129 | $10.75 | $22.9K | 0 | SEC↗ |
| Schaum Meredith | Gen Counsel and Chief Comp O | D To issuer | 2013-10-24 | 2013-10-28 | 2,937 | $10.75 | $31.6K | 0 | SEC↗ |
| Chang Michael N | Director | M Exercise deriv | 2013-09-04 | 2013-09-06 | 8,000 | — | $0 | 2,000 | SEC↗ |
| Chang Michael N | Director | M Exercise deriv | 2013-09-04 | 2013-09-06 | 100,000 | — | $0 | 0 | SEC↗ |
| Chang Michael N | Director | M Exercise deriv | 2013-09-04 | 2013-09-06 | 70,000 | — | $0 | 0 | SEC↗ |
| Chang Michael N | Director | M Exercise deriv | 2013-09-04 | 2013-09-06 | 30,000 | — | $0 | 0 | SEC↗ |
| Chang Michael N | Director | M Exercise deriv | 2013-09-04 | 2013-09-06 | 30,000 | — | $0 | 0 | SEC↗ |
| Chang Michael N | Director | M Exercise deriv | 2013-09-04 | 2013-09-06 | 30,000 | — | $0 | 0 | SEC↗ |
| Chang Michael N | Director | M Exercise deriv | 2013-09-04 | 2013-09-06 | 4,615 | — | $0 | 0 | SEC↗ |
| Chang Michael N | Director | M Exercise deriv | 2013-09-04 | 2013-09-06 | 9,000 | — | $0 | 11,000 | SEC↗ |
| Chang Michael N | Director | M Exercise | 2013-09-04 | 2013-09-06 | 9,000 | $11.41 | $102.7K | 441,761 | SEC↗ |
| Chang Michael N | Director | M Exercise | 2013-09-04 | 2013-09-06 | 30,000 | $10.75 | $322.5K | 432,761 | SEC↗ |
| Chang Michael N | Director | M Exercise | 2013-09-04 | 2013-09-06 | 70,000 | $6.90 | $483.0K | 1,018,956 | SEC↗ |
| Chang Michael N | Director | M Exercise | 2013-09-04 | 2013-09-06 | 100,000 | $9.70 | $970.0K | 948,956 | SEC↗ |
| Chang Michael N | Director | M Exercise | 2013-09-04 | 2013-09-06 | 30,000 | $9.70 | $291.0K | 372,761 | SEC↗ |
| Chang Michael N | Director | M Exercise | 2013-09-04 | 2013-09-06 | 4,615 | $2.17 | $10.0K | 342,761 | SEC↗ |
| Chang Michael N | Director | M Exercise | 2013-09-04 | 2013-09-06 | 8,000 | $9.56 | $76.5K | 1,026,956 | SEC↗ |
| Chang Michael N | Director | M Exercise | 2013-09-04 | 2013-09-06 | 30,000 | $6.90 | $207.0K | 402,761 | SEC↗ |
| Schaum Meredith | Gen.Counsel and Chief Comp O | J Other | 2013-05-15 | 2013-05-17 | 1,789 | $7.53 | $13.5K | 1,789 | SEC↗ |
| Sirota Eric | Chief Operating Officer | A Award | 2013-05-09 | 2013-05-13 | 10,000 | — | $0 | 12,129 | SEC↗ |
| Chang Michael N | Director | M Exercise deriv | 2013-04-23 | 2013-04-25 | 117,263 | — | $0 | 0 | SEC↗ |
| Chang Michael N | Director | M Exercise | 2013-04-23 | 2013-04-25 | 117,263 | $1.08 | $126.6K | 848,956 | SEC↗ |
| Chang Michael N | Director | M Exercise deriv | 2013-04-09 | 2013-04-11 | 84,375 | — | $0 | 0 | SEC↗ |
| Chang Michael N | Director | M Exercise deriv | 2013-04-09 | 2013-04-11 | 18,750 | — | $0 | 0 | SEC↗ |
| Chang Michael N | Director | M Exercise | 2013-04-09 | 2013-04-11 | 103,125 | $12.34 | $1.27M | 731,693 | SEC↗ |
| LICHTINGER PEDRO | Other | M Exercise deriv | 2013-04-08 | 2013-04-10 | 90,000 | — | $0 | 0 | SEC↗ |
| LICHTINGER PEDRO | Other | M Exercise deriv | 2013-04-08 | 2013-04-10 | 58,000 | — | $0 | 0 | SEC↗ |
| LICHTINGER PEDRO | Other | S Sale | 2013-04-08 | 2013-04-10 | 90,000 | $14.73 | $1.33M | 104,078 | SEC↗ |
| LICHTINGER PEDRO | Other | M Exercise | 2013-04-08 | 2013-04-10 | 58,000 | $11.41 | $661.8K | 162,078 | SEC↗ |
| LICHTINGER PEDRO | Other | M Exercise | 2013-04-08 | 2013-04-10 | 90,000 | $13.51 | $1.22M | 252,078 | SEC↗ |
| LICHTINGER PEDRO | Other | S Sale | 2013-04-08 | 2013-04-10 | 58,000 | $14.63 | $848.5K | 194,078 | SEC↗ |
| Chang Michael N | Director | M Exercise deriv | 2013-04-03 | 2013-04-05 | 103,125 | — | $0 | 0 | SEC↗ |
| Chang Michael N | Director | M Exercise deriv | 2013-04-03 | 2013-04-05 | 42,187 | — | $0 | 0 | SEC↗ |
| Chang Michael N | Director | M Exercise | 2013-04-03 | 2013-04-05 | 145,312 | $12.34 | $1.79M | 628,568 | SEC↗ |
| MCKINNELL HENRY A | CEO and Chairman of the Boar | A Award deriv | 2013-02-26 | 2013-02-28 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Webster Stephen W | CFO | A Award deriv | 2013-02-26 | 2013-02-28 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Gorbach MD Sherwood | Chief Scientific Officer, SV | A Award deriv | 2013-02-26 | 2013-02-28 | 60,000 | — | $0 | 60,000 | SEC↗ |
| AMPER LINDA E | SVP, Human Resources | A Award deriv | 2013-02-26 | 2013-02-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Schaum Meredith | Gen. Counsel,Chief Compl. Of | A Award deriv | 2013-02-26 | 2013-03-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AUERBACH MARK | Director | A Award | 2013-02-26 | 2013-02-28 | 2,500 | — | $0 | 20,000 | SEC↗ |
| ALTIG ANTHONY E | Director | A Award | 2013-01-01 | 2013-01-03 | 7,500 | — | $0 | 20,000 | SEC↗ |
| AUERBACH MARK | Director | A Award | 2013-01-01 | 2013-01-03 | 7,500 | — | $0 | 17,500 | SEC↗ |
| CHANG JOSEPH Y | Director | A Award | 2013-01-01 | 2013-01-03 | 7,500 | — | $0 | 109,806 | SEC↗ |
| GREBOW PETER E | Director | A Award | 2013-01-01 | 2013-01-03 | 7,500 | — | $0 | 15,000 | SEC↗ |
| MCKINNELL HENRY A | Director | A Award | 2013-01-01 | 2013-01-03 | 10,000 | — | $0 | 35,000 | SEC↗ |
| Newman Stephen L | Director | A Award | 2013-01-01 | 2013-01-03 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ZERBE ROBERT L MD | Director | A Award | 2013-01-01 | 2013-01-03 | 7,500 | — | $0 | 15,000 | SEC↗ |
| LICHTINGER PEDRO | CEO and President | P Buy | 2012-11-08 | 2012-11-19 | 11,000 | $9.08 | $99.9K | 104,078 | SEC↗ |
| Hartman Kurt M | General Counsel, SVP | A Award | 2012-08-11 | 2012-08-14 | 3,500 | — | $0 | 3,500 | SEC↗ |
| Gorbach MD Sherwood | Chief Scientific Officer, SV | A Award | 2012-08-11 | 2012-08-14 | 3,500 | — | $0 | 42,219 | SEC↗ |
| Newman Stephen L | Director | A Award deriv | 2012-07-23 | 2012-07-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Webster Stephen W | CFO | A Award deriv | 2012-06-29 | 2012-07-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Webster Stephen W | CFO | A Award | 2012-06-29 | 2012-07-02 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CHANG JOSEPH Y | Director | M Exercise deriv | 2012-06-11 | 2012-06-20 | 3,461 | — | $0 | 0 | SEC↗ |
| CHANG JOSEPH Y | Director | M Exercise | 2012-06-11 | 2012-06-20 | 3,461 | $0.65 | $2.2K | 105,767 | SEC↗ |
| CHANG JOSEPH Y | Director | S Sale | 2012-06-11 | 2012-06-20 | 3,461 | $15.30 | $53.0K | 102,306 | SEC↗ |
| AUERBACH MARK | Director | A Award | 2012-05-31 | 2012-06-20 | 2,500 | — | $0 | 10,000 | SEC↗ |
| ALTIG ANTHONY E | Director | A Award | 2012-05-31 | 2012-06-20 | 2,500 | — | $0 | 12,500 | SEC↗ |
| GREBOW PETER E | Director | A Award | 2012-05-31 | 2012-06-20 | 2,500 | — | $0 | 7,500 | SEC↗ |
| MCKINNELL HENRY A | Director | A Award | 2012-05-31 | 2012-06-20 | 10,000 | — | $0 | 25,000 | SEC↗ |
| CHANG JOSEPH Y | Director | A Award | 2012-05-31 | 2012-06-20 | 2,500 | — | $0 | 102,306 | SEC↗ |
| ZERBE ROBERT L MD | Director | A Award | 2012-05-31 | 2012-06-25 | 2,500 | — | $0 | 7,500 | SEC↗ |
| LICHTINGER PEDRO | CEO and President | J Other | 2012-05-15 | 2012-05-17 | 2,185 | $9.72 | $21.2K | 93,078 | SEC↗ |
| Gorbach MD Sherwood | SVP, Chief Medical Officer | J Other | 2012-05-15 | 2012-05-17 | 531 | $9.72 | $5.2K | 38,719 | SEC↗ |
| Papaz Gregory E. | SVP, Commercial Operations | J Other | 2012-05-15 | 2012-05-17 | 998 | $9.72 | $9.7K | 2,592 | SEC↗ |
| Prunty John D | CFO and SVP, Finance | A Award deriv | 2012-02-07 | 2012-02-09 | 35,000 | — | $0 | 35,000 | SEC↗ |
| LICHTINGER PEDRO | CEO and President | A Award deriv | 2012-02-07 | 2012-02-09 | 120,000 | — | $0 | 120,000 | SEC↗ |
| AMPER LINDA E | SVP, Human Resources | A Award deriv | 2012-02-07 | 2012-02-09 | 18,750 | — | $0 | 18,750 | SEC↗ |
| Gorbach MD Sherwood | SVP, Chief Medical Officer | A Award deriv | 2012-02-07 | 2012-02-09 | 24,320 | — | $0 | 24,320 | SEC↗ |
| Hartman Kurt M | Gen. Counsel, Chief Complian | A Award deriv | 2012-02-07 | 2012-02-09 | 18,750 | — | $0 | 18,750 | SEC↗ |
| Papaz Gregory E. | SVP, Commercial Operations | A Award deriv | 2012-02-07 | 2012-02-09 | 18,750 | — | $0 | 18,750 | SEC↗ |
| Shue Youe Kong | VP, Clinical Development | A Award deriv | 2012-02-07 | 2012-02-09 | 4,000 | — | $0 | 4,000 | SEC↗ |
| Chang Michael N | Director | A Award | 2012-01-01 | 2012-01-03 | 5,000 | — | $0 | 483,256 | SEC↗ |
| Che Tessie M | COO and SVP | A Award | 2012-01-01 | 2012-01-03 | 5,000 | — | $0 | 483,256 | SEC↗ |
| CHANG JOSEPH Y | Director | A Award | 2012-01-01 | 2012-01-03 | 5,000 | — | $0 | 99,806 | SEC↗ |
| AUERBACH MARK | Director | A Award | 2012-01-01 | 2012-01-03 | 5,000 | — | $0 | 7,500 | SEC↗ |
| ALTIG ANTHONY E | Director | A Award | 2012-01-01 | 2012-01-03 | 5,000 | — | $0 | 10,000 | SEC↗ |
| ZERBE ROBERT L MD | Director | A Award | 2012-01-01 | 2012-01-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| GREBOW PETER E | Director | A Award | 2012-01-01 | 2012-01-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| MCKINNELL HENRY A | Director | A Award | 2012-01-01 | 2012-01-03 | 5,000 | — | $0 | 15,000 | SEC↗ |